Tesamorelin is mainly studied as a growth hormone–releasing hormone analog that stimulates the body’s natural growth hormone pathway and increases IGF-1 activity. In research, it is commonly used to study visceral fat reduction, body composition, metabolic health, liver fat, and HIV-associated lipodystrophy. Tesamorelin is mainly studied as a growth hormone–releasing hormone analog that stimulates the body’s natural growth hormone pathway and increases IGF-1 activity. In research, it is commonly used to study visceral fat reduction, body composition, metabolic health, liver fat, and HIV-associated lipodystrophy. Its main approved medical use is reducing excess abdominal fat in adults with HIV-associated lipodystrophy, but research has also looked at its effects on visceral adipose tissue, liver fat/NAFLD in people with HIV, lean body mass, lipid metabolism, and glucose-related safety markers Tesamorelin is a synthetic GHRH analog studied for its effects on endogenous growth hormone release, IGF-1 signaling, visceral fat metabolism, body composition, and hepatic fat outcomes.
Tesamorelin
Product Information
Tesamorelin
Product Details
Research Applications
$49.99